Previous Page  15 / 22 Next Page
Information
Show Menu
Previous Page 15 / 22 Next Page
Page Background

Volume 7

OMICS Journal of Radiology

Radiology and Oncology 2018

July 16-17, 2018

Page 47

conference

series

.com

July 16-17, 2018 Dubai, UAE

Radiology and Oncology

2

nd

World Congress on

What is BLES?

The BLES consists of a biopsy “wand” and 5 metallic prongs (wand size depending) with their tips connected by an Extensible cutting

radiofrequency ring wire then pass from the wand and envelop an area of tissue ranging from 10 to 20 mm in diameter (depending

on wand size) in only 8 s. The Prongs pass RF waves into surrounding tissue in order to excise and allow haemostasis, but not to the

extent of damaging the sample. Allows excision of the entire breast mass or suspicious area as an intact complete mass may be with

safety margin.

Indications of Large needle procedures :

Therapeutic = Resection of Image evidence of Benign Lesions (if surgery is not preferred)

Fibroadenoms or Lipomas, Complex Cysts , Intraductal Vegetations, Papilloma, Hematomas , Scars

Advantages:

No hospitalization, Local anesthesia, Better targeting ,Small Incision ,No sutures ,No scar, Short duration of

procedure, Can resume normal activity in 30 minutes & Poor side effects.

Diagnostic

1. Suspicious lesions (BIRADS IV) with a size of less than 5mm

2. Mismatching radiography& pathology = Suspicious lesion & negative FNB or CNB

3. Mastopathic areas : for exclusion of suspected high risk lesions : ADH, radial scar, DCIS, lobular breast cancer

4. Unclassified/ suspicious microcalcification .

5. Focal architecture distortion .

6. Containdications to anasthesia and operations

Conclusion:

BLES & VAB are used as the primary method for histopathology diagnosis of suspicious small & borderline lesions as well as

the unclassified microcalcfications.

There are some limitations to BLES including; lactating females, patients with breast implants and patients presenting with a

lesion close to the skin or in the axillary tail.

BLES is favored in high risk lesions & DCIS considering the relative high underestimation rate associated with VAB and not

found with the BLES . Moreover BLES offers complete lesion removal with available margin evaluation.

Biography

Naglaa Abdel Razek is a graduate of Cairo University faculty of medicine the year 1993 and completed her studies for the MD in Radiology from the Cairo University

in the year 2003. And she completed her training in breast imaging and intervention in Germany, Italy and France. Since 1995, she is working as a staff member in

the radiology department and she was nominated as a professor of radiology since May 2013. She is one of the most recognized radiologists in Egypt working in

the field of breast cancer screening, diagnosis and intervention. She introduced to Egypt the technique of non-invasive removal of benign tumors of the breast using

the vacuum assisted biopsy and also she introduced a very new technique to Egypt , the breast lesion excision biopsy (BLES) and she is working with international

group to set guidelines for the use of such a new technique. Dr Naglaa is an active member in the Women’s Health Outreach Program at the Ministry of Health since

2007 and in October 2014 till May 2016 ,she was nominated as the General manager of Egypt breast cancer screening program and women health in Egypt and

she occupied the post of being the Minister Advisor in radiology for one year from January 2015 to January 2016. She is an active member and Board member of

many National & International societies, She is president and founder of the Pink foundation and Detect Breast course & she is an international Board member of

the American Association of Women Radiologists, European society of Radiology ,European Society of Breast Imaging & the Radiology Society of North America.

Prof. Naglaa also is the principle breast radiologist and interventionist in Alfa scan Radiology Center and she is the head of the breast unit since 2003 till present .

Naglaa has many national and international publications and has presented many presentations in national and international conferences especially concerned with

breast cancer. Dr. Naglaa’s favorite mission is to fight breast cancer.

naglaaabdelrazek@yahoo.com